1220 New Scotland Rd., Suite 201
Slingerlands, NY 12159

Send Fax to Retina Consultants

Fax: (518) 533-6556

Clinical Trials

This page showcases some of the various clinical trials that we have been involved with, bringing state of the art technologies and pioneering treatments to the people of New York’s Capital District and surrounding region.

We are currently enrolling patients in clinical trials with macular degeneration, diabetic retinopathy, macular edema and several other conditions. Upcoming studies, pending various approvals, will soon be enrolling patients with macular edema, uveitis, ocular inflammation, and other conditions.

Macular Degeneration

Alcon

Race

Macular Degeneration

Completed

This trial involved:

  • 2 drugs injected into an eye

A phase I study to evaluate the safety of anti-Complement (AL-78898A) Injections in addition to Lucentis.

Ophtotech

OPH1001

Macular Degeneration

Completed

This trial involved:

  • 2 drugs injected into an eye

A phase II study to evaluate the safety of anti-PDGF (E10030). Injections in addition to Lucentis.

Areds2

ForeseeHome Device Study

Macular Degeneration

Completed

This trial involved:

  • a non invasive home monitoring device

A non invasive device to detect conversion to neovascular AMN

Ophtotech

OPH3000

Macular Degeneration

Completed

This trial involved:

  • 2 drugs injected into an eye

A phase I study to evaluate the safety of Volociximab. Injections in addition to Lucentis

Retina Research Foundation

Intravitreal Remicade

Macular Degeneration & Diabetic Retinopathy

Completed

This trial involved:

  • a drug injected into an eye

A phase I-pilot study to evaluate the safety of intravitreal Remicade (Infliximab). Injections for patients with severe diabetic macular edema or choroidal neovascularization.

Ophtotech

OPH1000

Macular Degeneration

Completed

This trial involved:

  • 2 drugs injected into an eye

A phase I study to evaluate the safety of anti-PDGF. Injections in addition to Lucentis

Renegeron

View 1

Wet Macular Degeneration

Completed

This trial involved:

  • a drug injected into an eye

Phase 3 study to evaluate the VEGF Trap for wet Macular Degeneration

Areds2

AREDS2

Dry Macular Degeneration

Completed

This trial involved:

  • lutein, zeaxanthin, omega-3 fatty acids

Prevention of age related macular degeneration and cataracts with vitamin supplementation.

Sponsored by the National Institute of Health.

Retina Consultants

Salvage

Macular Degeneration

Completed

This trial involved:

  • a drug injected into an eye

A phase I/II study to evaluate Scotoma reduction and Limited Visual Acuity in a GE related macular degeneration.

Patients treated with LUCENTIS.

Sea Horizon

HORIZON FVF3426

Macular Degeneration

Completed

This trial involved:

  • a drug injection into an eye

Open label extension study with LUCENTIS (rhuFab V2). Therapy for Anchor and Marina patients.

Sea Sailor

Sailor

Macular Degeneration

Completed

This trial involved:

  • a drug injected into an eye

Open label study with LUCENTIS (rhuFab V2). Therapy for Age Related Macular Degeneration

Sea Marina

Marina

Macular Degeneration

Completed

This trial involved:

  • a drug injected into an eye
  • a drug injected to an arm vein
  • laser treatment to the eye

Ranibizumab (rhuFab V2). Therapy for patients with Minimally Classic Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.

Sea Anchor

Anchor

Macular Degeneration

Completed

This trial involved:

  • a drug injected into an eye
  • a drug injected into an arm vein
  • laser treatment to the eye

Ranibixumab (rhuFab V2) or Verteporfin (visudyne). Therapy for Patients with Mostly Classical Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.

Pfizer

Pfizer

Macular Degeneration

Completed

This trial involved:

  • a drug injected next to the eye

Phase I anti-VEGF therapy. Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.

Eyetech

Eyetech

Macular Degeneration

Completed

This trial involved:

  • a drug injected into the eye

Macugen Compassionate Use for Patients with Wet Macular Degeneration.

Vio

Vio

Macular Degeneration

Completed

This trial involved:

  • a drug injected into an arm vein
  • laser treatment to the eye

Vereporfin (Visudyne). Therapy for Patients with Entirely Occult Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.

Novartis

ADD-V

Macular Degeneration

Completed

This trial involved:

  • a drug injected into an arm vein
  • eye drops

Vereporfin (Visudyne) and Voltaren drops. Therapy for Patients with Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.

Genentech

Genentech/ROCHE Study

Wet Macular Degeneration

Enrollment Closed

This trial involves:

  • a drug injected into the eye

Phase II Study to evaluate effectiveness of anti-VEGF vs. Lucentis

Alcon

Hawk

Wet Macular Degeneration

Enrollment Closed

This trial involves:

  • a drug injected into the eye

A Phase III Study to evaluate longevity of anti-VEGF vs. Eylea

Uveitis

Novartis

Insure

Noninfectious Intermediate, Posterior or Panuveitis

Completed

This trial involved:

  • a drug injected into the vein

Dose-ranging phase III trial to assess a monoclonal antibodies to IL 17 (IN457 vs. Placebo)

Sanofi

Sanofi

Non-infectious, Intermediate, Posterior or Pan-Uveitis

Completed

This trial involved:

  • one drug injected subcutaneously

Phase II study to determine the efficacy of injectable subcutaneous drug.

Novartis

AIN457

Non-infectious Uveitis

Completed

This trial involved:

  • a drug injected into in the vein

Phase 2 study to evaluate monoclonal antibodies to IL 17 for uveitis

Clearside

Peachtree

Non-infectious uveitis with Macular Edema

Completed

Novermber 2015

This trial involved:

  • one drug injected into the eye

Phase III study to determine efficacy of Triamcinolone Acetonide Injectable Suspension

PPD

pSivida

Chronic Non-infectious Uveitis

Completed

November 2014

This trial involved:

  • one implant placed in the eye

A Phase III study to evaluate safety and efficacy of a Fluocinolone Acetonide Intravitreal insert

Diabetic Retinopathy

Retina Research Foundation

Intravitreal Remicade

Macular Degeneration & Diabetic Retinopathy

Completed

This trial involved:

  • a drug injected into an eye

A phase I/pilot study to evaluate the safety of intravitreal Remicade (Infliximab) Injections

Genentech

Rise FVF4168g

Diabetic Retinopathy

Enrollment Closed

This trial involves:

  • an oral drug taken daily

Intravitreal injections of Ranibizumab administered monthly for 24 months for patients with Diabetic Macular Edema

Lilly

RXXANT B7A-MC-MBCU

Diabetic Retinopathy

Completed

This trial involved:

  • a drug injected into the eye

Intravitreal Steroid for diabetic Macular Edema Laser for Diabetic Macular Edema

Central Retinal Vein Occlusion

Allergan

Allergan

Retinal Vein Occlusions

Study Closed

This trial involved:

  • a drug releasing implant injected into an eye

Intravitreal Steroid Implant for Vein Occlusions with Macular Edema